ArticleJournal of registry management2025
Inferring Unknown Race in Central Cancer Registries.
Article in Journal of registry management, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Completeness of race information is a criterion for data certification among United States central cancer registries. This paper presents a method for reducing unknown race information by as much as 75%, with 95% accuracy, race-specific sensitivity of 81-99%, and race-specific positive predictive value of 88-97%. The method, Bayesian Improved Surname Geocoding (BISG), has been in wide use in the social sciences and public health for more than 15 years. We use the publicly available North Carolina voter rolls as a proxy for cancer patients, drawing a sample of these persons that mimics the national distribution of cancer incidence by race and ethnicity. BISG has the potential to increase the accuracy of racespecific cancer incidence rates by as much as 3% in registries with the highest levels of missingness; in other registries, the effects will be negligible. The method has been incorporated into freely available computer code.
Indexed as
Identifiers
41281963PMC12636241What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.